These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 20412505)

  • 1. The relationship between average daily dose, medication adherence, and health-care costs among diabetic peripheral neuropathic pain patients initiated on duloxetine therapy.
    Chen SY; Wu N; Boulanger L; Fraser KA; Zhao Y
    Pain Pract; 2010; 10(6):530-9. PubMed ID: 20412505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in opioid use and healthcare costs among U.S. patients with diabetic peripheral neuropathic pain treated with duloxetine compared with other therapies.
    Zhao Y; Wu N; Chen S; Boulanger L; Police RL; Fraser K
    Curr Med Res Opin; 2010 Sep; 26(9):2147-56. PubMed ID: 20662557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medication adherence and healthcare costs among patients with diabetic peripheral neuropathic pain initiating duloxetine versus pregabalin.
    Zhao Y; Sun P; Watson P
    Curr Med Res Opin; 2011 Apr; 27(4):785-92. PubMed ID: 21303196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors associated with pain medication selection among patients diagnosed with diabetic peripheral neuropathic pain: a retrospective study.
    Chen S; Wu N; Boulanger L; Fraser K; Zhao Z; Zhao Y
    J Med Econ; 2011; 14(4):411-20. PubMed ID: 21615268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Duloxetine compliance and its association with healthcare costs among patients with diabetic peripheral neuropathic pain.
    Wu N; Chen S; Boulanger L; Fraser K; Bledsoe SL; Zhao Y
    J Med Econ; 2009 Sep; 12(3):192-202. PubMed ID: 19705975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medication adherence and healthcare costs among fibromyalgia patients treated with duloxetine.
    Zhao Y; Chen SY; Wu N; Fraser KA; Boulanger L
    Pain Pract; 2011; 11(4):381-91. PubMed ID: 21199311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An open-label 52-week clinical extension comparing duloxetine with routine care in patients with diabetic peripheral neuropathic pain.
    Wernicke JF; Wang F; Pritchett YL; Smith TR; Raskin J; D'Souza DN; Iyengar S; Chappell AS
    Pain Med; 2007 Sep; 8(6):503-13. PubMed ID: 17716324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain.
    Wernicke JF; Pritchett YL; D'Souza DN; Waninger A; Tran P; Iyengar S; Raskin J
    Neurology; 2006 Oct; 67(8):1411-20. PubMed ID: 17060567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dosing pattern comparison between duloxetine and pregabalin among patients with diabetic peripheral neuropathic pain.
    Sun P; Zhao Y; Zhao Z; Bernauer M; Watson P
    Pain Pract; 2012 Nov; 12(8):641-8. PubMed ID: 22335435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of medication adherence and healthcare costs between duloxetine and pregabalin initiators among patients with fibromyalgia.
    Zhao Y; Sun P; Watson P; Mitchell B; Swindle R
    Pain Pract; 2011; 11(3):204-16. PubMed ID: 20807351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Duloxetine versus routine care in the long-term management of diabetic peripheral neuropathic pain.
    Raskin J; Smith TR; Wong K; Pritchett YL; D'Souza DN; Iyengar S; Wernicke JF
    J Palliat Med; 2006 Feb; 9(1):29-40. PubMed ID: 16430342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Duloxetine for the management of diabetic peripheral neuropathic pain: evidence-based findings from post hoc analysis of three multicenter, randomized, double-blind, placebo-controlled, parallel-group studies.
    Kajdasz DK; Iyengar S; Desaiah D; Backonja MM; Farrar JT; Fishbain DA; Jensen TS; Rowbotham MC; Sang CN; Ziegler D; McQuay HJ
    Clin Ther; 2007; 29 Suppl():2536-46. PubMed ID: 18164920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opioid utilization and health-care costs among patients with diabetic peripheral neuropathic pain treated with duloxetine vs. other therapies.
    Wu N; Chen SY; Hallett LA; Boulanger L; Fraser KA; Patel CK; Zhao Y
    Pain Pract; 2011; 11(1):48-56. PubMed ID: 20602718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of duloxetine in the treatment of diabetic peripheral neuropathic pain in older patients.
    Wasan AD; Ossanna MJ; Raskin J; Wernicke JF; Robinson MJ; Hall JA; Edwards SE; Lipsius S; Meyers AL; McCarberg BH
    Curr Drug Saf; 2009 Jan; 4(1):22-9. PubMed ID: 19149522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of comorbid depression or anxiety on patterns of treatment and economic outcomes among patients with diabetic peripheral neuropathic pain.
    Boulanger L; Zhao Y; Foster TS; Fraser K; Bledsoe SL; Russell MW
    Curr Med Res Opin; 2009 Jul; 25(7):1763-73. PubMed ID: 19505204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health care costs in patients with painful diabetic peripheral neuropathy prescribed pregabalin or duloxetine.
    Burke JP; Sanchez RJ; Joshi AV; Cappelleri JC; Kulakodlu M; Halpern R
    Pain Pract; 2012 Mar; 12(3):209-18. PubMed ID: 21676163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initial duloxetine prescription dose and treatment adherence and persistence in patients with major depressive disorder.
    Liu X; Gelwicks S; Faries DE; Able SL
    Int Clin Psychopharmacol; 2010 Nov; 25(6):315-22. PubMed ID: 20706125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of duloxetine versus other treatments among veterans with diabetic peripheral neuropathic pain: a retrospective study.
    Zhao Y; Liu J; Zhao Y; Thethi T; Fonseca V; Shi L
    Pain Pract; 2012 Jun; 12(5):366-73. PubMed ID: 21951753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of pain medication selection among patients diagnosed with fibromyalgia.
    Boulanger L; Wu N; Chen SY; Nagar S; Fraser K; Bernauer MJ; Zhao Z; Zhao Y
    Pain Pract; 2012 Apr; 12(4):266-75. PubMed ID: 21899718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Duloxetine for the management of diabetic peripheral neuropathic pain: response profile.
    Pritchett YL; McCarberg BH; Watkin JG; Robinson MJ
    Pain Med; 2007; 8(5):397-409. PubMed ID: 17661853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.